Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,834 | 45,816 | 7,266 | 8,186 | 20,304 |
| Marketable Securities | 78,566 | 14,396 | N/A | 4,934 | N/A |
| Other current assets | 64 | 79 | 66 | 46 | 218 |
| TOTAL | $140,463 | $60,291 | $7,333 | $13,166 | $20,522 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 255 | 0 | 13 | 61 | 0 |
| TOTAL | $255 | $N/A | $13 | $61 | $N/A |
| Total Assets | $140,718 | $60,291 | $7,345 | $13,227 | $20,522 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,735 | 2,254 | 1,757 | 3,129 | 1,581 |
| Other current liabilities | N/A | 3,000 | N/A | N/A | N/A |
| TOTAL | $2,735 | $5,254 | $1,757 | $3,129 | $1,581 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 155 | 0 | 0 | 8 | 0 |
| TOTAL | $155 | $N/A | $N/A | $8 | $N/A |
| Total Liabilities | $2,890 | $5,254 | $1,757 | $3,137 | $1,581 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,692 | 6,113 | 3,491 | 2,639 | 2,521 |
| Common Shares | 7 | 6 | 3 | 13 | 13 |
| Retained earnings | -89,510 | -75,793 | -60,206 | -51,804 | -41,288 |
| Other shareholders' equity | 131 | 36 | -14 | 9 | -3 |
| TOTAL | $137,828 | $55,037 | $5,588 | $10,090 | $18,941 |
| Total Liabilities And Equity | $140,718 | $60,291 | $7,345 | $13,227 | $20,522 |